Created in 1975 (Belgium), LYCAMED own 359 sister brands and 2214 competing brands. LYCAMED is a brand of UCB, listed on the stock exchange of Bruxelles. The International Securities Identification Number (ISIN) of UCB is BE0003739530. LYCAMED is part of the Biotechnology activity sector.

LYCAMED is a brand of UCB (UCB) Share price

International deposit : 1975 Business sector Biotechnology

Share price and profitability of the share UCB (LYCAMED)

Buy UCB share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 122.00

Portfolio valuation
UCB (LYCAMED) over 5 years* EUR 211.77

Stock market history UCB (LYCAMED)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
UCB

Zogenix
Zogenix
Handl Therapeutics
Handl Therapeutics
Engage Therapeutics
Engage Therapeutics
Ra Pharmaceuticals
Ra Pharmaceuticals
UCB
UCB
See more brands of UCB

Rival brands
LYCAMED

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS